001377167 000__ 02674cam\\2200517\i\4500 001377167 001__ 1377167 001377167 003__ OCoLC 001377167 005__ 20211016003141.0 001377167 007__ he\bmb024bbca 001377167 008__ 210303s2019\\\\dcua\\\\bb\\\f000\0\eng\d 001377167 035__ $$a(OCoLC)1240365399 001377167 040__ $$aGPO$$beng$$erda$$cGPO$$dOCLCO$$dOCLCF$$dISE 001377167 043__ $$an-us--- 001377167 049__ $$aISEA 001377167 074__ $$a1028-B (MF) 001377167 0860_ $$aY 4.W 36:115-HL 03 001377167 088__ $$aSerial no. 115-HL03 (United States. Congress. House. Committee on Ways and Means) 001377167 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Ways and Means.$$bSubcommittee on Health,$$eauthor. 001377167 24514 $$aThe opioid crisis :$$bremoving barriers to prevent and treat opioid abuse and dependence in Medicare : hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Fifteenth Congress, second session, February 6, 2018. 001377167 24630 $$aRemoving barriers to prevent and treat opioid abuse and dependence in Medicare 001377167 264_1 $$aWashington :$$bU.S. Government Publishing Office,$$c2019. 001377167 300__ $$aiii, 102 pages :$$billustrations ;$$c24 cm 001377167 336__ $$atext$$btxt$$2rdacontent 001377167 337__ $$amicroform$$bh$$2rdamedia 001377167 338__ $$amicrofiche$$bhe$$2rdacarrier 001377167 500__ $$a"Serial no. 115-HL03." 001377167 500__ $$aShipping list no.: 2021-0037-M. 001377167 504__ $$aIncludes bibliographical references. 001377167 50520 $$tOpioid deaths surge in 2016: number of opioid overdose deaths by category, 1999 to 2016 -- Impact of medication-assisted treatment for opioid addiction on Medicaid expenditures and health services utilization rates in Vermont. 001377167 533__ $$aMicrofiche.$$b[Washington, D.C.] :$$cU.S. Government Printing Office,$$d[2020]$$e2 microfiche : negative. 001377167 61020 $$aCenters for Medicare & Medicaid Services (U.S.)$$xRules and practice. 001377167 61027 $$aCenters for Medicare & Medicaid Services (U.S.)$$2fast$$0(OCoLC)fst00767996 001377167 650_0 $$aMedicare beneficiaries$$xDrug use$$xPrevention. 001377167 650_0 $$aOpioids$$xOverdose$$zUnited States$$xPrevention. 001377167 650_0 $$aOpioid abuse$$zUnited States$$xPrevention. 001377167 650_0 $$aDrugs$$xPrescribing$$xCorrupt practices$$xPrevention. 001377167 650_0 $$aDrug abuse$$xTreatment$$zUnited States. 001377167 650_7 $$aDrug abuse$$xTreatment.$$2fast$$0(OCoLC)fst00898588 001377167 651_7 $$aUnited States.$$2fast$$0(OCoLC)fst01204155 001377167 655_7 $$aLegislative hearings.$$2fast$$0(OCoLC)fst01910825 001377167 655_7 $$aRules.$$2fast$$0(OCoLC)fst01423857 001377167 655_7 $$aLegislative hearings.$$2lcgft 001377167 77608 $$iPrint version:$$aUnited States. Congress. House. Committee on Ways and Means. Subcommittee on Health.$$tOpioid crisis$$w(DLC) 2018487445$$w(OCoLC)1096432809 001377167 77608 $$iOnline version:$$aUnited States. Congress. House. Committee on Ways and Means. Subcommittee on Health.$$tOpioid crisis$$w(OCoLC)1096432416 001377167 852__ $$bdfich 001377167 852__ $$bedoc$$hY 4.W 36:115-HL 03 001377167 85640 $$uhttps://purl.fdlp.gov/GPO/gpo118244 001377167 909CO $$ooai:library.usi.edu:1377167$$pGLOBAL_SET 001377167 980__ $$aBIB 001377167 980__ $$aEGOV 001377167 982__ $$aGovernment E-Resource 001377167 983__ $$aOnline 001377167 994__ $$aC0$$bISE